Protalix BioTherapeutics set to join Russell 3000 Index

CARMIEL - Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary... | June 11, 2023

Related Keywords

Brazil ,United States ,American ,Chiesi Farmaceutici ,Dror Bashan ,Chuck Padala ,Pfizer Inc ,European Medicines Agency ,European Union ,Protalix Biotherapeutics Inc ,Exchange Commission ,Drug Administration ,Chief Executive ,Private Securities Litigation Reform Act ,Medicines Agency ,News Publishing ,